Indoco Remedies share price falls over 4% as Goa unit gets 4 USFDA observations
Indoco Remedies shares fell 2% as USFDA inspected its Sterile Facility in Goa from Feb 20-28, 2023, and classified it as OAI with four observations.
Indoco Remedies shares slumped over 4% on Monday's trading session after the company informed the exchanges that its Sterile Facility (Plant II) located at Goa has received four observations in form 483 issued by the United States Food and Drug Administration (USFDA). In the early trade the stock slipped over 2%. Indoco Remedies share price opened at the day's intraday high level of ₹354.75 apiece on BSE.
Get the best recommendations on Stocks, Mutual Funds and more based on your Risk profile!Let’s get started